X0303 4 2011-01-26 0 0000799694 Oncologix Tech Inc. OCLG 0000904550 SILVERMAN ANTHONY P.O. BOX 8832 GRAND RAPIDS MI 49518-8832 1 1 1 0 CEO & President Stock Options (Common Stock) .17 2011-01-26 4 D 0 20000 .17 D 2006-08-09 2014-08-09 Common Stock 20000 50000 D Stock Options (Common Stock) .17 2011-01-26 4 D 0 50000 .17 D 2005-08-09 2014-08-09 Common Stock 50000 0 D Stock Options (Common Stock) .03 2011-01-26 4 A 0 14000 .03 A 2011-01-07 2018-01-07 Common Stock 14000 14000 D On January 7, 2001, the Board of Directors of the Issuer determined that it would be in the best interest of the Company and its shareholders to reduce the number of authorized but unissued shares of common stock to outstanding stock purchase rights. If successfully accomplished, such reduction would serve to increase the number of shares available for the sale to finance the continuing operations of the Company. Accordingly, the board of Directors specifically authorized the exchange of presently outstanding rights to purchase 1,475,000 shares at prices between $0.165 and $1.33 for the rights to purchase up to 295,000 shares at a price of $0.03 per share. The transaction being reported on hereby reflects the acceptance by the filer of such exchange. The exchange was made on January 26, 2011. Mr. Silverman holds a direct interest in 17,770,850 sgares of common stock and a direct interest in 14,000 stock options to purchase common stock. Anthony Silverman 2011-01-28